INTRODUCTION
Over the past 65 years, many factors have influenced the development and disbandment of hospital-based infusion teams. Originally, state laws required physicians to deliver all IV infusion therapy, but the laws were changed in the early 1960s. 1 Owing to these legal changes, highly specialized and skilled nurses were needed to assume infusion responsibilities, thus driving the development of infusion teams within many US hospitals. The 1990s brought patient safety concerns associated with excessive working hours for medical interns and residents. Inserting peripheral IV catheters, troubleshooting all types of catheter problems, and giving IV medications could easily be shifted to an infusion team of skilled nurses, thus reducing the workload of these physicians. 2 , 3 At the turn of the 21st century, costs and cost containment in health care became a serious issue. Business consulting companies recommended disbanding infusion teams in many hospitals as a cost-cutting measure, thus shifting all infusion responsibility to the overloaded staff nurses. Infusion teams that are established as only a cost center in the hospital accounting system may be easy targets for cost-cutting efforts, as opposed to those teams that are set up as revenue centers. Currently, the United States is in the early stages of restructuring many aspects of financing its health care system with the introduction of value-based payments and pay-for-performance programs. The impact of these changes on infusion teams is yet to be determined; however, the renewed emphasis on improving patient team, or a team with limited hours of operation. Maintaining the status quo of staff nurses performing all infusion therapy could be 1 option; however, the issues, problems, and negative clinical outcomes already included in the proposal provide information about why these options are not the wisest choice. Financial data for each alternative should be analyzed so a clear comparison can be made. For example, improving outcomes and resolving problems with infusion therapy that is managed by staff nurses may require a substantial investment in staff development, along with processes to measure performance improvement. These ongoing costs may exceed the costs of an infusion team.
Finally, the proposed action must fit within the hospital's stated mission, vision, and strategic plans. Most strategic plans for hospitals include goals involving quality of patient care and wise financial management, goals that are thoroughly consistent with those for safe delivery of infusion therapy.
The business case will always be developed from the perspective of the organization that will be paying for the proposed innovation-a hospital, in the case of an infusion team. Nonetheless, other entities are affected by the decision about the proposed innovation. 7 , 8 Third-party payers of health care 9 have higher costs when the length of stay is increased due to infusionrelated complications. One argument against an infusion team is that decreasing length of stay will not financially benefit the hospital, as the daily rate is being charged for each day of the patient stay. Research has shown that the largest revenues for the hospital come in the early stage of hospitalization when diagnostic and therapeutic procedures are being performed. After that period, nursing care is still required, but the daily net revenue production decreases. This means that shorter hospital stays produce higher revenues while freeing the bed for another patient who would then move into an initial period of greater daily revenue generated. 10 This business concept is known as inpatient throughput .
A case-matched cohort study of CLABSI in pediatric patients found that 10 CLABSI patients would occupy a bed for a total of 310 days and generate $2 021 628 in net revenue. The same 310 days would allow for 14 patients without CLABSI to occupy the bed for a total of $2 325 904 in net revenue, an increase in net revenue of $304 276. 10 For Medicare patients and billing based on the diagnosis-related group (DRG), 11 reducing the length of stay will decrease costs to the hospital since no additional billing per day is possible.
An additional perspective is that of the patient and society as a whole. Obviously the patient is deeply appreciative of skillful venipuncture on the first attempt, the absence of complications, and no medication errors; however, these benefits do not necessarily redound to the hospital. Many innovations may prove favorable for strong clinical data for comparison and careful financial analysis to secure the funding for the proposal.
Secondly, it can be viewed as the outcome of the decision to support the recommended service. The business case is made when the organization recognizes a financial return on the investment in a reasonable time period. A business case may also be present if decision makers believe that a positive impact on organizational function will accumulate over a reasonable time frame. 6 Consequently, the structured proposal is required in order to obtain administration approval for the desired project and for the organization to realize the positive financial return on the investment.
The proposal includes an analysis of where the hospital currently is with the specific issues, where it wants to be regarding challenges, and the process for getting there. Clinical outcome data should be collected and analyzed. While data from published studies are helpful, data from the specific hospital provide a more precise picture of what is occurring. Specific trends for problems may include unacceptable rates of central-line associated bloodstream infection (CLABSI), regardless of many interventions already implemented. Other infusionrelated complications that should be included are incidence rates or prevalence data on IV medication errors, infiltration, extravasation, phlebitis, vein thrombosis, iatrogenic pneumothorax during central venous catheter insertion, and venous air emboli associated with any type of vascular access device. Data from infusionrelated incident reports and sentinel event reports should be assessed. Claims of negligence or malpractice associated with infusion therapy must be included.
The proposal should analyze national and local priorities pertaining to the project. Examples of national priorities related to infusion-associated outcomes include hospital-acquired conditions from the Centers for Medicare & Medicaid Services (CMS). The hospital cannot bill Medicare when these conditions occur, and this list now includes 4 infusion-related conditions: air emboli, blood incompatibility, vascular catheter-associated infections, and pneumothorax from central venous catheter insertion. Many other national initiatives, such as medication errors, alarm fatigue, transfusion practices, and needlestick and other sharps injuries, should be assessed.
The proposal must provide a clear understanding of exactly what is being put forward (eg, an infusion team that meets the INS definition), the scope of service for this team, the staffing mix (eg, number of RNs, LP/VNs, and other assistive personnel), purchase of new capital equipment (eg, ultrasound machines), hours of operation, and how patient needs will be met if the proposal constitutes less than 24-hour, 7-days-a-week coverage by the team.
Alternatives to the proposed infusion team should be discussed, including starting a smaller catheter insertion Payment for services provided by US hospitals comes from private insurance companies, government payments from Medicare and Medicaid, and payment directly from patients without insurance. Medicare and Medicaid payments are fixed amounts based on the patient's diagnosis and represent a significant discount from the chargemaster prices. There are at least 750 types of DRGs 13 with the amount of payment for each determined by the Inpatient Prospective Payment System (IPPS). The specific payment varies based on local and regional operational costs and salary requirements, making it necessary to ascertain specific DRG payments for each hospital for calculations in a business case. Many insurance companies have followed the government's lead by also paying a fixed fee per diagnosis or a fixed daily fee. In calculating costs for a business case proposal, the percentages of payments from each type of payer may be useful.
Costs include direct, indirect, and opportunity costs. Each hospital will have methods and processes for cost accounting to support management decisions. While the infusion nurse manager may not have in-depth knowledge of cost calculations, there is a need for a basic understanding of different types of costs. Additionally, members of the financial department can serve as resources for supplemental information and calculations regarding costs.
Direct costs include all costs for operating a specific unit of the organization, but direct costs could also be analyzed as costs of patient care. Salaries for all members of the proposed infusion team (eg, RNs, unlicensed assistive personnel, secretary), employment taxes, and benefits are direct costs. The costs for acquiring capital equipment such as ultrasounds, electrocardiography (ECG) guidance technology, and storage carts are direct costs. Other direct costs include office and storage space for the infusion team, and a communication system (eg, pagers or telephones for team members on duty) must also be included.
When calculating the costs of operation for an infusion team, the time the nurse manager spends on administrative duties (eg, budgeting, staffing) would be included; however, if the analysis is for a specific patient care activity, managers' administrative time or clerical time would not be included. 12 Costs of peripheral IV catheters and a start kit may be allocated to the nursing care unit instead of an infusion team; however, these costs must be considered when analyzing the costs of this procedure. Labor costs of the personnel performing the procedure will include salary, employer-paid taxes, and benefits. Direct costs for an infusion team should be broken down by initial start-up costs (eg, training new personnel or decreased productivity during start-up) and ongoing operational costs (eg, salaries, equipment maintenance, and performance monitoring). the patient, but the hospital paying for that innovation will not see a financial benefit. 7 
FINANCIAL ANALYSIS FOR THE BUSINESS CASE
Financial analysis is required to make the business case for instituting, sustaining, or expanding an infusion team. This means that the group working on the business case must be knowledgeable about hospital budgeting processes and practices, revenue sources, and cost-accounting practices, or seek the assistance of those who are.
Most nursing units in hospitals are set up as cost centers, meaning they have responsibility only for controlling expenses. The nursing unit does not generate the patients admitted or control prices charged and thus has no control over the revenue brought into the hospital. A revenue center shows both costs expended and revenue generated for the hospital. Hospital units are designated as revenue centers when the services provided are used by a portion of, but not all, patients. The revenue center provides a way to measure service consumption for different patients. 12 According to Perucca, the infusion team should be established as a revenue center as well as a cost center. 13 This structure allows for the capture of highly specialized infusion services performed only by the infusion team. Tracking and analyzing these services document the financial contributions of the infusion team, showing revenue to offset the costs.
Fees or prices for all procedures and products are established through the chargemaster system, a large computer file containing all devices and procedures generating a patient charge. 13 The infusion nurse leader is the expert to work with the accounting and coding departments to establish the chargemaster prices for all infusion procedures and resources. 13 Each price includes the costs of supplies, labor, overhead, and the percentage of markup used by the specific hospital. The amount of money received by the hospital in payment for all services is discounted from the chargemaster prices.
The case mix index (CMI) is a number assigned to a hospital based on the acuity of patients in that specific facility and is used to determine the hospital's payment. Hospitals with patients having more complex needs, more critical diagnoses, or more difficult surgery will have a higher number assigned and therefore receive higher payments from all payers. For instance, a community hospital may have a CMI of 1.5 or 1.6, but the CMI for an academic medical center may be 2.0. When calculating costs based on all patients in the hospital, this number will be important to know. Improvements in care, such as a reduction in CLABSI rates, may result in a decrease in the CMI and a corresponding decrease in revenue. This is an example of the hospital, would have been avoided if this complication had not occurred. The likelihood of the complication occurring would have been greatly decreased had the peripheral catheter been placed in a large vein of the forearm rather than a vein of the wrist, adequate catheter and joint stabilization devices used, and complete site assessment performed before the rapid injection of the contrast agent.
Other examples of cost avoidance can be found. One study of pharmacists' interventions in an emergency department documented cost avoidance of more than $1 million during a 4-month study period and potential cost avoidance of more than $3 million when the data were extrapolated for a 1-year period. 16 Another study analyzed the costs of CLABSI in 54 patients and compared the direct and indirect costs to the amount of revenue paid to the hospital for treating these infections. In this patient group, the average payment was $64 894, and the average cost was $91 733, representing an average loss of $26 839 per patient. This study documented a total loss of $1 449 306 in all 54 patients. 17 It is important to note this study was conducted before Medicare stopped payments for the complicating condition of CLABSI. Today, the financial loss would be even greater; thus, prevention of CLABSI represents a substantial example of cost avoidance.
Patient safety and patient satisfaction has taken a leading role in changing health care. Patients expect quality care from qualified professionals. Infusion therapy represents an invasive procedure performed on virtually all hospital inpatients. 18 Hospital costs associated with defense of lawsuits from infusion-related complications can be significant, including increases in insurance premiums, time of risk management and clinical staff for data collection, depositions, and trial appearances. Loss of reputation and subsequent loss of new patients can occur with a decrease in patient satisfaction or when complication rates are publicly reported. Rates for hospital-acquired conditions are available to the public through the Hospital Compare Web site. 19 Higher rates of nursing turnover due to unacceptable stress levels on staff nurses should also be considered. [20] [21] [22] One report of nurse liability issues identified failure to properly monitor and maintain infusion sites in 13.2% of all closed claims from 2006 to 2010. The total amount paid for these claims was $960 000. 23 Another aspect of cost is the difference between fixed and variable costs. Labor is generally a fixed cost, while costs of supplies are variable because they differ for each patient. 12 Salaries and benefits for the infusion team are fixed costs. Costs for CVAD insertion can be established by a standardized list for the procedure, although variations will occur if additional supplies and longer staff time are required to accomplish the procedure.
Indirect costs are those that are assigned to another unit within the hospital or are costs within the specific unit but not related directly to patient care. 12 Costs for laundry or central supply services would not have an impact when considering the costs of the infusion team as a hospital department; however, some of these costs may need to be allocated when calculating the costs for a specific procedure such as insertion of a central vascular access device (CVAD).
Opportunity costs occur because an alternative use for the money was sacrificed. Money for a proposed infusion team could be spent in other ways. For instance, money could have been requested for expansion of the staff development department or new infusion pumps are needed. Anticipated revenue generated by the other proposed service or equipment would be compared to the anticipated revenue generated by the infusion team. The revenue to be generated by the infusion team would need to be greater than that anticipated from the other new service or equipment in order for the decision makers to support the infusion team. Revenue from the other new service or equipment is sacrificed because of the decision to invest in the infusion team.
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Cost analysis involves understanding and applying related terms of cost savings and cost avoidance, also called cost aversion. In basic terms, cost savings occur when a product or service is bought for less money than previously paid. Cost savings occur for peripheral IV catheters when a change in product or the contracted purchase price results in less money spent. If the contract price for peripheral catheters decreases by 50 cents each, the purchase of 10 000 catheters would represent a savings of $5000.
Cost avoidance/aversion refers to actions taken to reduce future costs, although the initial preventive action may be more costly than the current practices. When payment is based on a DRG for a Medicare patient, shorter length of stay means costs for additional days are avoided. Costs are avoided when a peripheral IV catheter is removed after completion of therapy without complications. When a peripheral catheter used for power injection in radiology produces an extravasation injury and subsequent compartment syndrome in a 70-year-old patient, the costs include immediate surgical fasciotomy to decompress the extremity, followed by many additional days as an inpatient and a second surgery to close the original incision on the fasciotomy. The costs of 2 surgical procedures, necessary medications (eg, antibiotics), additional hospital days, required physical therapy, and outpatient care would constitute the total costs of the complication. Medicare is paying the hospital expenses under the DRG system; however, the total payment may fall short of the actual costs for this treatment. Costs exceeding the Medicare payment, plus costs of subsequent litigation brought by the patient against the The group of individuals involved in creating the business case proposal for an infusion team varies among hospitals. This group should include those with the knowledge and skills necessary to make the appropriate financial analysis.
The process is divided into different sections or phases ( Table 2 ) . The first task is to identify the issue(s) to be addressed. Department heads (eg, critical care, emergency department, outpatient services), thoughtleaders, and stakeholders who are affected by these issues should also be contacted for input. Potential solutions should be developed through these discussions. Leading with the problem, rather than the desired solution, allows for an open-minded, analytical approach. Key administrative leaders in the hospital should be approached to ascertain if these issues are an organizational concern. Support from these administrative Prices for inpatient care are first established through the chargemaster system as described earlier. Unfortunately, patients without health insurance may be billed the actual charges established in the system. Rates are now negotiated by hospital administrators, especially since the inception of managed care for Medicare and Medicaid patients, along with private insurance payers expecting the most favorable rates. One traditional method of pricing is the ratio of cost to charges (RCC) method. For example, the total cost of operating a revenue-centered hospital department is $2 million annually, and Medicare patients compose 60% of the patients served by this department, for a total of $1.2 million coming to this revenue center from Medicare payments. 12 The relative value unit 24 is another method of assigning costs to a unit of work. The necessary costs are determined for 1 basic procedure and assigned the value of 1. Costs for all other procedures are measured against the costs of the basic procedure and assigned a relative value unit (RVU). For a monthly assessment, the RVUs are totaled, and the operating costs are divided by the total RVUs performed to determine the cost per unit of work. 12 If the costs of inserting a short peripheral IV catheter using a standard set of supplies and nursing labor is established as $50 with an RVU of 1, then a peripherally inserted central catheter (PICC) 25 insertion with a cost of $400 would have a relative value of 8. If the monthly cost of operating the infusion team is $7500 and the RVUs total 125, the cost per unit of work is $60.
Activity-based costing (ABC) 12 has been applied in health care for only the past 15 to 20 years. As discussed, most other cost-accounting techniques are based on time (eg, minutes in the operating room) or patient volume (eg, patient-days). ABC identifies factors or drivers that generate the costs. 12 The intervention of inserting a PICC would include cost drivers listed in Table 1 . A patient scheduled for PICC insertion without any unusual issues would have a lower cost than a patient with an urgent need for PICC insertion due to the failure to establish peripheral sites or to recognize the need for a PICC. This system would allow for easy identification of cost drivers such as urgent, unplanned insertion or factors contributing to insertion difficulty. One technological advancement of using ECG to determine tip location eliminates the need for chest radiograph on most patients. Eliminating the radiograph also eliminates the waiting time for radiograph results, the need to repeat the radiograph for aberrant tip locations, the concern over which licensed independent practitioner will "release" the PICC for use, and the issues associated with allowing nurse-inserters to assess the chest radiograph for tip location.
The primary emphasis for estimating costs and revenues is to be totally accurate, methodical, and comprehensive. Omitting or underestimating costs will not be people will be a tremendous help with cost information and analytical techniques and processes currently being used in the facility.
Situational analysis can offer additional insights into the current problems and possible solutions. Strengths, weaknesses, opportunities, and threats (SWOT) for the proposed intervention are analyzed. Another acronym for a similar analysis is PEST: politico-legal, economic, social, and technical factors. 26 A standard template, if currently used at the hospital, should guide the contents of the written business case. If one is not available, suggested templates for initiating an infusion team and for expanding an existing team are included in appendices.
CONCLUSION
In our current situation of health care consumerism, patients are responsible for more out-of-pocket health care expenses; therefore, they are demanding quality along with increased services. As health care consumers become more knowledgeable, their expectation for patient-centered, high-quality care increases. Lower costs can come from care that is better coordinated, safer, and delivered in a more efficient manner. Infusion teams can be the source of lower costs.
Developing a business case will require a significant investment of time and skills; however, this is required to gain administrative support. Infusion nurses are highly skilled and knowledgeable members of the clinical team. Infusion nurse leaders see the benefits of infusion nursing services; however, we must be able to thoroughly document and communicate these advantages to the financial decision makers in the organization. This requires expanding our knowledge and skills into the business aspects of health care. 
Executive Summary
This section provides an overview of the initiative to implement an infusion team. Typically, this section is developed after the other sections are completed, as it constitutes a summary of the details provided.
Issue
This section should concisely and accurately describe the problems to be addressed by an infusion team. Use business and financial terms to highlight the issues associated with providing cost-effective, quality infusion nursing care using a dedicated team of qualified, skilled, knowledgeable, and competent infusion nurses.
Anticipated Outcomes
This section should identify the primary outcome of the project, specifically a dedicated team of infusion nurses intended to enhance patient safety and satisfaction while reducing labor costs, inventory of infusion supplies, and other related costs.
Recommendation
This section briefly describes how the project will address the business problem and how results will be achieved. State the specific recommendation for an infusion team with a description of the nursing units to be serviced and the number of hours per day and days per week for operation of this team. The project to develop an infusion team will be led by key stakeholders of the organization and will include the collection and analysis of baseline or pre-implementation data, ongoing collection and analysis of data related to key performance indicators during implementation, and comparison at full implementation to baseline for measures of success. It is anticipated that the implementation of an infusion team will allow more efficient use of nursing labor, reduce costs of infusion supplies and inventory, reduce infection rates, significantly improve aspects of patient care and safety, and enhance patient satisfaction.
Justification
This section provides reasons for implementing the infusion team and why this approach was selected. Published literature should be consulted to identify the benefits of an infusion team. Consultation with other organizations that have implemented an infusion team could reveal cost savings, reduction of infections related to infusion devices, reduction of infusion-related complications, decreased wait time for device insertion, fewer insertion attempts, and changes in patient satisfaction metrics.
Business Case Team
This section describes the roles of the team members who will develop the business case for an infusion team. A single individual should coordinate creation of the business case. This person is often seen as the "project champion" who can prepare locally based analysis of what needs to be done and how this may be achieved. 1 List all members of the team and their current roles within the organization.
The following table suggests the team of health care professionals responsible for creating and presenting this pro-posal to the final decision makers. They will be responsible for the collection and analysis of information used in the creation of this business case. Retrospective data collection and analysis of outcomes over the last year could demonstrate an increase in costs associated with the infusion therapy process. Supply costs and waste, complication rates, incident or unusual occurrence reports, sentinel events and serious safety events are valuable data to assess. Changes in patient satisfaction scores related to IV skills among nursing staff may have changed over time. If possible, compare these scores over a specific period.
1,2
Organizational Impact
This section describes how the proposed infusion team will modify or affect the organization. It should also explain any newly created roles and how existing roles may change as a result of this new infusion team.
The role of the infusion team manager and staff must be decided along with a thorough discussion of how the new infusion team will interact with other facility operations (eg, radiology, outpatient services, emergency department). There should be clear statements about the scope of infusion therapy services assigned to the infusion team versus those activities that will be the responsibility of the staff nurse.
Many aspects of organizational change could occur from the development of an infusion team. The need for staff development and mentoring of all patient care staff may be required to improve those aspects of infusion care assigned to the nursing staff. Expert infusion nurses may be expected to manage product evaluation and quality improvement projects, identify other risk management strategies, and serve on related organizational committees. The section provides a high-level explanation of how the organization will be affected as a result of the infusion team.
The infusion team members could augment infusion practice within the organization by serving as consultants, educators, and advisors to the primary care team. Infusion team members could lead process changes focusing on reduction of operational losses and improved patient outcomes. The financial impact of these activities on the organization must be calculated and analyzed.
Proposal Overview
This section describes high-level information about the proposed infusion team including a description, goals and objectives, performance criteria, assumptions, constraints, and milestones. Consolidate all specific information into this section to provide an easy understanding of the baseline business problem, impacts, and recommendations.
Proposal Description
This section describes the purpose of the proposed infusion team, the goals and objectives, performance criteria, assumptions, constraints, and milestones associated with the infusion team implementation.
Improved patient outcomes and a positive impact on financial performance will always be the desired goal of the infusion team. Infusion therapy includes numerous frequent nursing interventions and is one of the most invasive procedures performed in virtually all hospital departments and clinical service areas. Currently, infusion therapy practice is a shared responsibility among numerous disciplines in the facility. Nursing, radiology, emergency services, and critical care all provide a wide variety of infusion therapy. This includes all types of vascular access device (VAD) insertion; routine maintenance of the VAD; complication identification and treatment; configuring, programming, and monitoring complicated systems for infusion of complex fluid and medication combinations; monitoring parenteral nutrition solutions; and managing transfusion of numerous blood components. Professionals with different training and competence levels perform the procedures, which may generate variability in performance and outcomes. Costs of care and complications rates for each discipline or specialty area may be necessary.
The proposed infusion team would address this variability in practice by establishing a more consistent standardized approach to infusion practice. Practice standardization allows for accurate measurement of those interventions producing positive outcomes, both clinically and financially.
Improve success rate of SPC insertions when this is assigned to staff nurses Success rate of insertion on first attempt exceeds the established threshold [3] [4] [5] Decreased incidence of phlebitis Using standard criteria for identifying and staging phlebitis, the incidence of infusion phlebitis is below the established threshold.
4-6
Decreased incidence of infiltration and extravasation
Using standard criteria for identifying and staging infiltration, the incidence of infiltration and extravasation is below the established threshold.
5,6
Patient satisfaction with SPC insertion
The patient satisfaction score related to SPC insertion exceeds the established threshold.
7
Occlusion of CVADs The incidence of occlusion of CVADs is below the established threshold.
5,6
CLABSI The incidence of CLABSI is at or near zero.
8,9
Timely insertion of SPC The wait-time for SPC insertions is below established threshold.
3,5,10
Dislodgment of VADs The incidence of VAD dislodgment is below established threshold due to adequate use of stabilization devices.
11,12
Standardization of supplies Reduction in IV supply budget through standardization across all departments including 
Performance
The following table lists the key resources and services and their anticipated outcomes, which can be used to measure the effectiveness of an infusion team.
Assumptions
This section provides an initial list of assumptions that underlie the project. Assumptions are statements about something that is taken for granted or a belief without proof. There should be adequate knowledge about each statement before it is included as an assumption. While there could be a risk of rejection by highlighting negative assumptions, it is necessary to address these issues since avoiding them could mean immediate rejection of the proposal. Additional assumptions can be added as the project moves forward.
Assumptions could include the details of patient care that will remain the same. Purchasing prices for applicable devices may change with contract negotiations; however, the prices used for all calculations should be transparent. Other assumptions could include the mix of payers (eg, Medicare, Medicaid, private insurers) and the percentage of each in the facility.
The following assumptions may apply to the implementation of an infusion team:
• The organization's budget is sufficient to support an infusion team.
• There is sufficient nursing expertise in infusion therapy to staff the infusion team.
• There is support from nursing staff and administration for the establishment of an infusion team.
• Baseline data for evaluation of an infusion team are available or there is a means to obtain such data.
Constraints
This section provides an initial list of constraints, restrictions, or limitations that underlie the project. Additional constraints may be added as the project moves forward. While this section highlights negative aspects of the proposed infusion team, it is mandatory that these be included.
The major constraints that always seem apparent are the limitations of organizational budgets; however, other constraints could occur, such as the acquisition and merger of multiple facilities into one organization.
The following constraints may or may not be present in the organization:
• Limited funds to support the infusion team (salaries, benefits, supplies, overhead)
• Lack of nursing expertise necessary for an infusion team (documented expertise in infusion therapy, such as national certification) • Insufficient baseline data of key performance indicators, which would serve as the basis for the effect of the infusion team • Resistance from nursing/medical staff to the concept of an infusion team
Proposed Milestones
This section lists the milestones that mark progression of the infusion team implementation and the targeted completion dates. Progress toward the goals can easily be measured by this plan. For instance, retrospective data collection and analysis would require a set number of weeks or months, followed by the need to collect and analyze outcome data in a prospective manner.
Milestones/Deliverables Target Date
Forming the task force to create the business case 
Alignment with Strategic Goals
The infusion team business case should show congruence with the organization's mission, goals, and strategic plan. Those who are involved in preparing the business case should obtain a copy of these, commonly available in policies and procedures, marketing materials, and Web sites. Generally, these statements are global; however, more emphasis is now placed on adherence to:
• National Patient Safety Goals from the Joint Commission, especially those related to infection prevention, medication administration, and equipment alarms ( http://www.jointcommission.org/standards_information/ npsgs.aspx ) • Hospital Care Quality Information from the Consumer Perspective (HCAHPS) ( http://www.hcahpsonline. org/home.aspx ) • Patient satisfaction measures • Organizational data, if available, for baseline CLABSI infection rates, peripheral venipuncture attempts, infiltration/extravasation rates, IV supply inventory and monthly costs, and IV-related incidents, sentinel and/or serious safety events
Plan Goals/Objectives Relationship to Project
Mission for the organization Provide the highest quality of health care services to the community.
This project will provide quality care in reference to NPSG to reduce the incidence of CLABSI, increase consumer satisfaction by decreasing IV start attempts, and reduce the incidence of infiltration/extravasation.
Annual goals for the organization
Provide cost-effective care. This project will reduce labor costs by more efficient use of staff and reduce IV supply costs by reducing inventory or streamlining inventory management.
Annual strategic plan for the organization Enhance stature within the community. This project will provide data that can be shared through publication about the high quality of care provided relative to infusion procedures.
Abbreviations: CLABSI, central line-associated bloodstream infection; IV, intravenous; NPSG, National Patient Safety Goals .

Cost-Benefit Analysis
Many consider this one of the most important parts of a business case, as it is often the costs or savings projection that affects the final approval to move forward. It is important to quantify the financial benefits of the development of an infusion team as much as possible in the business case. This is usually done in the form of a cost-benefit analysis. The purpose of this is to illustrate the costs associated with the proposed change and compare them with the benefits and savings to demonstrate the value to the organization.
This section should include the salary, benefits, and payroll expenses for infusion team members. It is preferable to use organization-specific data; however, data from published literature could be used. Infusion nurse experts drive anticipated savings from more efficient time management, reduction in wait time (thus improving patient throughput), and reduction in time to perform a variety of procedures. Catheter use can also demonstrate a reduction in costs as a result of increased competency. 4 A review of your current supply costs associated with an IV start can be used as a baseline. Two examples of estimating costs can be found in a 2010 article in the Journal of Infusion Nursing. 13 Costs of infusion-related complications can be high, especially when those costs are not reimbursed due to rules for hospital-acquired conditions. One study analyzed the treatment costs for catheter-related bloodstream infection (CR-BSI) and compared those costs to the amount of revenue generated by these patients. In 54 patients with CR-BSI, the study documented a loss of $1.44 million.
14 Reduction in these complications and their associated costs can be used to offset the costs of the infusion team staff due to their higher level of knowledge and skill.
The following table captures the cost and savings with the development of the infusion team. This cost/benefit table provides a picture of the annual impact. 
Alternative Analysis
As with most business issues, there could be multiple ways to address the problem. The analysis in this business case supports the option of an infusion team as the most appropriate method for solving the business problems; however, a brief discussion of alternative approaches is necessary. This discussion should include an explanation of the reason(s) for not choosing these alternatives.
Alternatives Reasons for Not Selecting
Maintain the status quo with all members of the health care team inserting all VADs and performing all infusion therapy.
Analysis of the current costs of labor and inventory indicates this is the highest cost option. Current methods are associated with the clinical outcomes now seen (unacceptably high rates of CLABSI, iatrogenic pneumothorax during CVAD insertion, thrombophlebitis, IV medication errors, etc). The current rates of complications and errors have not improved regardless of the other strategies employed. Absence of reimbursement for treating hospital-acquired conditions means that hospital costs will continue to increase.
CVAD insertion by all physicians; SPC insertion by all nursing staff; all nursing staff responsible for infusion therapy practices
Intensive education and training for all nursing staff about infusion therapy would be time-and labor-intensive and cost-prohibitive.
CVAD insertion by a designated small group of nurses and radiology technologists; all nursing staff responsible for infusion therapy practices CVAD inserters would not have time to provide support for nursing staff with infusion-related issues and challenges. Limited hours of operation for CVAD insertion would not provide the same standard of care for all hours of the day and all days of the week. Cost savings would not be realized for SPC insertion or other infusion-related products. Complication rates would not be altered because of the lack of expert support services from infusion nurses.
Abbreviations: CVAD, central vascular access device; SPC, short peripheral catheter; VAD, vascular access device .
Approvals
This document would require administrative signatures confirming their approval of this project.
The signatures of the people below indicate an understanding of the purpose and content of this document.
These signatures indicate approval of the proposed project and that the next steps for development of an infusion team may be taken .
Executive Summary
This section provides an overview of the initiative to expand an infusion team. Typically, this section is developed after the other sections are completed as it constitutes a summary of the detail provided.
Issue
This section should concisely and accurately describe the problem(s) to be addressed by expansion of the present infusion team. This may involve the current staffing levels for the infusion team, increasing demands for services provided by the infusion team, and unmet patient needs.
Anticipated Outcomes
This section should identify the primary outcome of expansion of the infusion team, including improving patient throughput in the health care system by adequate staffing or expansion of service hours for the infusion team. Improvement in all aspects of patient safety and cost reduction or cost containment should be emphasized.
Recommendation
This section briefly describes how the project will address the business problem and how results will be achieved. State the specific recommendation for expansion of the current infusion team.
Expansion of an infusion team will be led by key stakeholders of the organization. The collection and analysis of baseline data include current productivity data (eg, types and number of procedures performed) and incidence or prevalence data of complications and errors. Ongoing collection and analysis of data should be related to key performance indicators during implementation and compared at full implementation to baseline for measures of success. It is anticipated that the expansion of an infusion team will reduce costs of infusion supplies and inventory, along with more appropriate throughput of patients in the health care system producing more appropriate transfer to other service providers (eg, home, long-term, or ambulatory care). Further reduction in all complication rates (eg, central line-associated bloodstream infection [CLABSI] , iatrogenic pneumothorax during insertion of a central vascular access device [CVAD], intravenous [IV] medication errors) is likely. These improvements will significantly improve aspects of patient care and safety and enhance patient satisfaction.
Justification
This section provides reasons for implementing the project and why this approach was selected. The primary purpose for expansion of an existing infusion team is to meet patient needs. This could be related to changes in patient acuity, increasing numbers of patients in need of infusion services, and/or expansion of services to other departments not previously covered by the infusion team.
Business Case Team
This section describes the roles of the team members who will be involved in the development of the business case. The business case should be coordinated by a single individual. This person is often seen as the "project champion" who can prepare a locally based analysis of what needs to be done and how this can be achieved. 1 List all members of the team and their current roles within the organization.
The following table suggests the team of health care professionals presenting this proposal. They will be responsible for the collection and analysis of information used in the creation of the business case for the expansion of an infusion team. Examine the growth of the PICC insertion procedures since the service began and compare this to the current number of procedures. Has the number of team members remained the same or changed in any way? What other supportive services were the team able to provide at the beginning (eg, difficult SPC insertion), but the growth of PICC insertion now decreases availability of the team members to provide the same level of support to the nursing staff? Compare the changes in annual SPC purchases over this same period of time.
Through data collection and analysis of outcomes over the last year, demonstrate how these changes are associated with an increase in costs. Include purchase costs for all catheters and supplies, along with the costs of labor and overhead. In addition, include data on increases in complication rates, such as phlebitis and infiltration, along with changes in patient satisfaction scores related to infusion therapy services.
Organizational Impact
This section describes how the proposed change will modify or affect the organization. It should also explain any new roles that would be created or how existing roles may change as a result of the infusion team expansion.
Adding more full-time equivalent (FTE) members and transitioning the team from an "insertion team" to an "infusion team" will relieve the burden on staff nurses while enhancing patient outcomes and satisfaction. This transition to an infusion team will allow more time for training and mentoring of the nursing staff in best practices for infusion therapy that remains within their scope of responsibility (eg, infusion pump management, administration of IV medications and blood transfusion). 3 The expansion of the infusion team will allow for the team members to be involved with product evaluation, greater standardization of infusion practices throughout the organization, more effective measurement of clinical outcomes, and enhancement of staff development and risk management. The team members will lead process changes that can help reduce operational losses and result in improved patient outcomes and revenue savings.
The existing reporting structure would not change. The current PICC team manager would assume responsibility for the additional team members.
Proposal Overview
This section describes high-level information about the proposal to include a description, goals and objectives, performance criteria, assumptions, constraints, and milestones. Consolidate all specific information into this section to provide an easy understanding of the baseline business problem, impacts, and recommendations.
Proposal Description
This section describes the purpose of the expansion of the infusion team, the elements of the project, and a general description of how it will be executed.
Improved patient outcomes and a positive impact on financial performance will always be the desired goal of the infusion team.
Infusion therapy includes frequent nursing interventions and is one of the most invasive procedures performed in virtually all hospital departments and clinical service areas. Currently, infusion therapy practice is a shared responsibility among numerous disciplines in the facility. Nursing, radiology, emergency services, and critical care all provide a wide variety of infusion therapy. This includes all types of vascular access device (VAD) insertion; routine maintenance of the VAD; complication identification and treatment; configuring, programming, and monitoring complicated systems for infusion of complex fluid and medication combinations; monitoring parenteral nutrition solutions; and managing transfusion of numerous blood components. Professionals with different training and competence levels perform the procedures, which may generate variability in performance and outcomes. Costs of care and complications rates for each discipline or specialty area may be necessary.
The proposed expansion of the infusion team aims to address this variability in practice by establishing a more consistent approach to infusion practice. Expansion of the current infusion team will enhance patient throughput, reduce delays of infusion services, and improve patient outcomes by reducing complications. As a result of these changes, the likelihood of reducing costs and increasing revenues is increased.
Expansion of the infusion team will mean that services can be expanded to outpatients where the billable procedures are different. For inpatients, infusion therapy procedures such as PICC/CVAD insertion are included in the capitated fees (eg, diagnosis-related group [DRG] for Medicare, yearly contracted amounts for health maintenance organizations [HMOs]). PICC insertions for outpatients are billed by the procedure, thus enhancing revenue for the organization.
Readmission of patients is now being discouraged and may result in loss of revenue. Providing consultation services to long-term, ambulatory, or home care companies may lead to a reduction in readmissions from unrecognized complications such as infection or thrombosis.
Providing appropriate VAD insertion more rapidly due to expanded staff numbers and/or hours of service could result in more rapid treatment of disease processes, resulting in faster discharge and filling that same inpatient bed with another patient.
Goals and Objectives
This section lists how the expansion of the infusion team will meet the goals and objectives of the organization.
The table below highlights the corporate goals and how the investment in an infusion therapy team would support them.
Business Goal/Objective Description
Patient-centered care Encouraging patients and family members to be involved with choosing the VAD best suited for them to manage long-term infusion therapy in the home
Creation of a fair and just culture in the organization Encouraging all staff to speak out about problems (eg, excessive venipuncture for peripheral catheter insertion) and errors (eg, IV medication errors) with honesty and respect for all involved
Reduce overall supply costs Reduction of supply costs associated with infusion therapy procedures through improving venipuncture proficiency rates and appropriate use of administration sets and other add-on devices due to standardization and staff development Improve patient outcomes Reduction of infusion-related complications through use of infusion nurse specialists and staff development regarding infusion therapy practices
Performance
The following Unit rounds by infusion team member Compliance with standards and guidelines for VAD removal as soon as it is no longer medically necessary Improve success rate of SPC insertions Success rate of insertion on first attempt exceeds threshold. [4] [5] [6] Decreased incidence of phlebitis Using standard criteria for identifying and staging phlebitis, the incidence of infusion phlebitis is below threshold. [5] [6] [7] Decreased incidence of infiltration Using standard criteria for identifying and staging infiltration, the incidence of infiltration is below threshold. 6, 7 Patient satisfaction with SPC insertion The patient satisfaction score related to SPC insertion exceeds threshold. 8 Occlusion of CVADs The incidence of occlusion of CVADs is below threshold. 6,7
CLABSI
The incidence of CLABSI is below threshold.
9,10
Timely SPC insertions The wait-time for SPC insertions is below threshold. 
Assumptions
This section provides an initial list of assumptions that underlie the expansion of the infusion team.
Assumptions are statements about something that is taken for granted or a belief without proof. There should be adequate knowledge about each statement before it is included as an assumption. While there could be a risk of rejection by highlighting negative assumptions, it is necessary to address these issues since avoiding them could mean immediate rejection of the proposal. Additional assumptions can be added as the project moves forward.
The following assumptions may apply to the expansion of an infusion team:
• The organization's budget is sufficient to support the expansion of an infusion team.
• There is sufficient nursing expertise in infusion therapy to staff the expanded infusion team.
• There is support from nursing staff and administration for the expansion of an infusion team.
• Baseline data from which the effect of the expanded infusion team can be evaluated are available or there is a means to obtain such data.
Constraints
This section provides an initial list of constraints that underlie the project. Additional constraints may be added as the project moves forward. While this section highlights negative aspects of the proposed expanded infusion team, it is mandatory that these be included.
• Limited funds to support an expansion of the infusion team (salaries, benefits, supplies, overhead) on either a part-time or full-time basis • Lack of experienced staff necessary for the infusion team expansion and the subsequent need for recruiting qualified staff
Proposed Milestones
This section lists the milestones that mark progression of the expansion of the infusion team and the targeted completion dates. Progress toward the goals can easily be measured by this plan. Productivity data (eg, procedures performed) should already be available; however, the full complement of outcome data may need to be collected and analyzed.
Milestones/Deliverables Target Date
Alignment with Strategic Goals
Expansion of the infusion team should show congruence with the organization's mission, goals, and strategic plan. Those who are involved in preparing the business case should obtain a copy of the organization's mission, goals, and strategic plan, which is commonly available in policies and procedures, marketing materials, and Web sites. Generally, these statements are global; however, more emphasis is now placed on adherence to:
• National Patient Safety Goals from the Joint Commisssion, especially those related to infection prevention, medication administration, and equipment alarms. http://www.jointcommission.org/standards_information/ npsgs.aspx • Hospital Care Quality Information from the Consumer Perspective (HCAHPS) http://www.hcahpsonline. org/home.aspx .
• Patient satisfaction measures.
• Organizational data, if available, for baseline CLABSI rates; peripheral venipuncture attempts; infiltration/ extravasation rates; IV supply inventory and monthly costs; and IV-related incidents, sentinel events, and serious safety events.
Cost-Benefit Analysis
Many consider this one of the most important parts of a business case, as it is often the costs or savings projection that affects the final approval to move forward. It is important to quantify the financial benefits of the expansion of an infusion team as much as possible in the business case. This is usually done in the form of a cost-benefit analysis. The purpose of this is to illustrate the costs associated with the proposed change and compare them with the benefits and savings to demonstrate the value to the organization.
This section should include the salary and benefits for additional team members. Determining the savings to offset the extra FTEs should be demonstrated based on data from your own institution, or from the literature.
Catheter use can also demonstrate a reduction in costs as a result of increased competency. 4 A review of your current supply costs associated with SPC insertion can be used as a baseline. An example of estimating costs can be found in the Sept/Oct 2010 Journal of Infusion Nursing . 12 Costs of infusion-related complications can also be valuable in demonstrating the impact of increasing staff who possess a higher level of competence.
The following table captures the cost and savings with the expansion of the infusion team. This cost-benefit table provides a picture of the annual impact:
